Kedrion SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kedrion SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH138106D
  • |
  • Pages: 24
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company's products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products for the treatment of orphan diseases. Kedrion also offers contract manufacturing services, technology transfer services and biological safety center services. The company works in partnership with Italian National Health Service to achieve self-sufficiency in plasma-derived therapies. It has manufacturing plants in Italy, Hungary and the US. The company has operational presence in Asia, Europe, North America and South America. Kedrion is headquartered in Barga, Lucca, Italy.

Kedrion SpA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Kedrion SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Kedrion SpA, Medical Devices Deals, 2012 to YTD 2018 10

Kedrion SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Kedrion SpA, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Kedrion Acquires RhoGAM Line Of Products From Ortho-Clinical Diagnostics 12

Partnerships 13

National Immunobiological, Pharmstandard and Kedrion Biopharma form Joint Venture 13

Biotest Pharma Enters into Distribution Agreement with Kedrion Biopharma 14

Licensing Agreements 15

United Biotech Enters into Licensing Agreement with Kedrion 15

Debt Offering 16

Kedrion Raises USD397 Million in Public Offering of 3% Bonds Due 2022 16

Kedrion Raises USD514 Million in Private Placement of Bonds 17

Acquisition 18

Kedrion Completes Acquisition Of Somerset Labs From Ortho-Clinical Diagnostics 18

Fondo Strategico Italiano Acquires 18.6% Stake In Kedrion From Sestant For USD 188 Million 19

Kedrion SpA-Key Competitors 20

Kedrion SpA-Key Employees 21

Kedrion SpA-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24

List of Figures

Kedrion SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Kedrion SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Kedrion SpA, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Kedrion SpA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Kedrion SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Kedrion SpA, Deals By Therapy Area, 2012 to YTD 2018 8

Kedrion SpA, Medical Devices Deals, 2012 to YTD 2018 10

Kedrion SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Kedrion Acquires RhoGAM Line Of Products From Ortho-Clinical Diagnostics 12

National Immunobiological, Pharmstandard and Kedrion Biopharma form Joint Venture 13

Biotest Pharma Enters into Distribution Agreement with Kedrion Biopharma 14

United Biotech Enters into Licensing Agreement with Kedrion 15

Kedrion Raises USD397 Million in Public Offering of 3% Bonds Due 2022 16

Kedrion Raises USD514 Million in Private Placement of Bonds 17

Kedrion Completes Acquisition Of Somerset Labs From Ortho-Clinical Diagnostics 18

Fondo Strategico Italiano Acquires 18.6% Stake In Kedrion From Sestant For USD 188 Million 19

Kedrion SpA, Key Competitors 20

Kedrion SpA, Key Employees 21

Kedrion SpA, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 250 INR 17743
Site License
USD 500 INR 35485
Corporate User License
USD 750 INR 53228

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com